Drug Profile


Alternative Names: Circulase™

Latest Information Update: 06 Jun 2006

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Mitsubishi Pharma Corporation
  • Class Prostaglandins
  • Mechanism of Action Prostaglandin E1 agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Diabetic neuropathies; Intermittent claudication; Peripheral arterial disorders; Peripheral arterial occlusive disorders; Reperfusion injury

Most Recent Events

  • 11 May 2006 Discontinued - Phase-II for Peripheral arterial occlusive disorders in Japan (unspecified route)
  • 11 May 2006 Discontinued - Phase-III for Peripheral arterial occlusive disorders in USA (unspecified route)
  • 06 Dec 2004 This compound is still in active development for Peripheral Arterial Occlusive Disorders
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top